A central physiological role for estrogen in bone tissue maintenance is implicated by skeletal phenotypes observed in association with aromatase deficiency in aromatase knockout mice (arKO) [40] and aromatase gene mutations in humans, including loss of bone mass and osteoporosis in male and female subjects (reviewed, [41]). This evidence concerns the gene CYP19A1 and osteoporosis.